Advertisement
CordovaCann Corp.

CordovaCann Corp. Fundamental Analysis

CDVA.CNCNQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.05
$0.01(25.000%)
Canadian Market is Open · 10:56
Advertisement

CordovaCann Corp. Fundamental Analysis

CordovaCann Corp. (CDVA.CN) shows moderate financial fundamentals with a PE ratio of -2.08, profit margin of -19.22%, and ROE of 43.99%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE43.99%
PEG Ratio0.01

Areas of Concern

Operating Margin2.49%
Current Ratio0.18
We analyze CDVA.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 43.5/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
43.5/100

We analyze CDVA.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

CDVA.CN struggles to generate sufficient returns from assets.

ROA > 10%
-41.33%

Valuation Score

Excellent

CDVA.CN trades at attractive valuation levels.

PE < 25
-2.08
PEG Ratio < 2
0.01

Growth Score

Weak

CDVA.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

CDVA.CN shows balanced financial health with some risks.

Debt/Equity < 1
-0.83
Current Ratio > 1
0.18

Profitability Score

Moderate

CDVA.CN maintains healthy but balanced margins.

ROE > 15%
43.99%
Net Margin ≥ 15%
-19.22%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CDVA.CN Expensive or Cheap?

P/E Ratio

CDVA.CN trades at -2.08 times earnings. This suggests potential undervaluation.

-2.08

PEG Ratio

When adjusting for growth, CDVA.CN's PEG of 0.01 indicates potential undervaluation.

0.01

Price to Book

The market values CordovaCann Corp. at -0.88 times its book value. This may indicate undervaluation.

-0.88

EV/EBITDA

Enterprise value stands at -0.80 times EBITDA. This is generally considered low.

-0.80

How Well Does CDVA.CN Make Money?

Net Profit Margin

For every $100 in sales, CordovaCann Corp. keeps $-19.22 as profit after all expenses.

-19.22%

Operating Margin

Core operations generate 2.49 in profit for every $100 in revenue, before interest and taxes.

2.49%

ROE

Management delivers $43.99 in profit for every $100 of shareholder equity.

43.99%

ROA

CordovaCann Corp. generates $-41.33 in profit for every $100 in assets, demonstrating efficient asset deployment.

-41.33%

Following the Money - Real Cash Generation

Operating Cash Flow

CordovaCann Corp. generates limited operating cash flow of $923.45K, signaling weaker underlying cash strength.

$923.45K

Free Cash Flow

CordovaCann Corp. produces free cash flow of $906.77K, offering steady but limited capital for shareholder returns and expansion.

$906.77K

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

FCF Yield

CDVA.CN converts 16.52% of its market value into free cash.

16.52%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.08

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.009

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.88

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.40

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.83

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.18

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.44

vs 25 benchmark

ROA

Return on assets percentage

-0.41

vs 25 benchmark

ROCE

Return on capital employed

-0.11

vs 25 benchmark

How CDVA.CN Stacks Against Its Sector Peers

MetricCDVA.CN ValueSector AveragePerformance
P/E Ratio-2.0833.74 Better (Cheaper)
ROE43.99%404.00% Weak
Net Margin-19.22%-40219.00% (disorted) Weak
Debt/Equity-0.830.81 Strong (Low Leverage)
Current Ratio0.185.53 Weak Liquidity
ROA-41.33%-281.00% (disorted) Weak

CDVA.CN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews CordovaCann Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ